Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Phase I-II Trial of Tandem Autologous Transplantation with Melphalan Followed by Total Marrow Irradiation Ablative Therapy in Patients with Responding or Stable Mutiple Myeloma.

George Somlo, MD, Paul Frankel, PhD, Ricardo Spielberger, MD, Chatchada Karanes, MD, Amrita Krishnan, MD, Pablo Parker, MD, Leslie Popplewell, MD, Firoozeh Sahebi, MD, Timothy Schultheiss, PhD, Neil Martin Kogut, MD, David S. Snyder, MD, Anthony Selwyn Stein, M.D., Stephen J. Forman, MD, Jeffrey Wong, MD

Blood (2012) 120 (21): 3151.

https://doi.org/10.1182/blood.V120.21.3151.3151

Published: 2012

Journal Articles

Conditional Survival and Cause-Specific Mortality in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Hematologic Malignancy Over Three Decades

Saro H. Armenian, DO, MPH, Can-Lan Sun, Ph.D, Tabitha Vase, George Mills, III, Liezl Atencio, Liton Francisco, Jocelynne Palmer, PhD, Ari VanderWalde, MD, MPH, F. Lennie Wong, PhD, Joseph Rosenthal, MD, Neil Martin Kogut, MD, Leslie Popplewell, MD, David S. Snyder, MD, Anthony Selwyn Stein, M.D., Margret O'Donnell, MD, Stephen J. Forman, MD, Smita Bhatia, MD, MPH

Blood (2012) 120 (21): 606.

https://doi.org/10.1182/blood.V120.21.606.606

Published: 2012

Journal Articles

Comparative Analysis of Autologous Hematopoietic Cell Transplantation with Radioimmunotherapy (RIT) Based Conditioning Versus Total Body Irradiation (TBI) for High-Risk Diffuse Large Cell Lymphoma (DLCL): Toxicity and Efficacy

Amrita Krishnan, M.D., Joycelynne Palmer, PhD, Auayporn Nademanee, M.D., Andrew Raubitschek, MD, Dave Yamauchi, Neil Martin Kogut, MD, Laura Federico, Nicole Tsai, Stephen Forman, M.D.

Blood (2010) 116 (21): 32.

https://doi.org/10.1182/blood.V116.21.32.32

Published: 2010

Journal Articles

Extramedullary Relapse Following Reduced Intensity AlloHCT for Adult AML.

Neil Martin Kogut, MD, Joycelynne Palmer, PhD, Ni-Chun Tsai, MS, Joyce Collins, PhD, Margaret O'Donnell, M.D., F.R.C.P.C., Anthony Selwyn Stein, M.D., Ricardo Spielberger, MD, Stephen Forman, MD

Blood (2010) 116 (21): 3467.

https://doi.org/10.1182/blood.V116.21.3467.3467

Published: 2010

Journal Articles

Early Mortality After Hematopoietic Cell Transplantation (HCT) for Hematologic Malignancies Performed In the Recent Era

Lester A. Laddaran, B.A., Can-Lan Sun, Ph.D., Ari M. VanderWalde, MD, MPH, Liton Francisco, B.S., Saro Armenian, D.O., M.P.H., Jennifer Berano Teh, M.D., F. Lennie Wong, Ph.D., Chatchada Karanes, MD, Neil Martin Kogut, MD, Amrita Krishnan, M.D., Auayporn Nademanee, M.D., Margaret O'Donnell, M.D., F.R.C.P.C., Pablo Parker, M.D., Leslie Popplewell, M.D., Anthony Selwyn Stein, M.D., Stephen J. Forman, M.D., Smita Bhatia

Blood (2010) 116 (21): 902.

https://doi.org/10.1182/blood.V116.21.902.902

Published: 2010

Journal Articles

High Rate of Complete Remission (CR) and Upgraded Response with Weekly Maintenance Bortezomib Post Single Autologous Peripheral Stem Cell Transplant (PSCT) In Patients with Multiple Myeloma. Results of a Phase II Prospective Study

Firoozeh Sahebi, M.D., Amrita Krishnan, M.D., Leonardo Farol, MD, Ji-Lian Cai, MD, George Somlo, MD, Leslie Popplewell, M.D., R. Spielberger, M.D., Neil Martin Kogut, MD, Chatchada Karanes, MD, Christopher Ruel, Paul Frankel, Eunicia Reburiano, Margret O'Donnell, MD, Stephen Forman

Blood (2010) 116 (21): 2399.

https://doi.org/10.1182/blood.V116.21.2399.2399

Published: 2010

Journal Articles

A Phase II Study of Sequential Velcade/Thalidomide/ Dexamethasone (VTD) as Maintenance Therapy Post Single Autologous Peripheral Stem Cell (PSCT) in Patients with Multiple Myeloma.

Firoozeh Sahebi, Amrita Krishnan, MD, FACP, George Somlo, MD, Leslie Popplewell, P. Parker, Ji-Lian Cai, MD, PhD, Len Farol, MD, Ricardo Spielberger, Neil Martin Kogut, MD, Chatchada Karanes, Christopher Ruel, Paul Frankel, Fermin Arceo, Lupe Duarte, CRRC, Margaret O'Donnell, MD, Stephen J Forman, MD

Blood (2009) 114 (22): 3403.

https://doi.org/10.1182/blood.V114.22.3403.3403

Published: 2009

Journal Articles

Total Marrow Irradiation (TMI): A New Ablative Regimen as Part of Tandem (T) Autologous Peripheral Blood Progenitor Cell Transplant (AT) for Patients (pts) with Multiple Myeloma (MM).

George Somlo, M.D., F.A.C.P., Ricardo Spielberger, MD, Paul Frankel, Chatchada Karanes, MD, Amrita Krishnan, MD, FACP, Pablo Miguel Parker, MD, Leslie Popplewell, Firoozeh Sahebi, Tim Schultheiss, Neil Martin Kogut, MD, An Liu, David S. Snyder, MD, Stephen J. Forman, Jeffrey Y. Wong

Blood (2008) 112 (11): 3326.

https://doi.org/10.1182/blood.V112.11.3326.3326

Published: 2008

Journal Articles

Similar Outcome with Early Reduced Intensity Conditioning (RIC) Allogeneic Transplant to Autologous-Non-Myeloablative Allogeneic (Auto-Allo) Transplant in Patients with Multiple Myeloma.

Sahebi Firoozeh, MD, Jeffery R. Schriber, M.D., Ricardo Spielberger, M.D., Ji-Lian Cai, M.D., Neil Martin Kogut, M.D., Peter M. Falk, M.D., Pablo Miguel Parker, M.D., Amrita Krishnan, M.D., Leslie Popplewell, M.D., Chatchada Karanes, M.D., Dajun Qian, PhD., Stephen J. Forman, M.D., George Somlo, M.D.

Blood (2007) 110 (11): 3030.

https://doi.org/10.1182/blood.V110.11.3030.3030

Published: 2007

Journal Articles

Peripheral Hematopoietic Stem Cell Mobilization and Collection Efficacy Is Not an Independent Prognostic Factor for Autologous Stem Cell Transplantation.

Shirong Wang, MD, Auayporn P. Nademanee, MD, Dajun Qian, PhD, Andrew Dagis, PhD, Hyun-Soon Park, RN, Joy Fridey, MD, Eileen Patricia Smith, MD, David S. Snyder, MD, Ravi Bhatia, MD, Peter M. Falk, MD, Candace Kay, MT, Young Sun Kim, MD, Neil Martin Kogut, MD, Joycelynne Palmer, PhD, Joseph Rosenthal, MD, George Somlo, MD, Anthony Selwyn Stein, MD, Shan Yuan, MD, Stephen J. Forman, MD

Blood (2006) 108 (11): 5434.

https://doi.org/10.1182/blood.V108.11.5434.5434

Published: 2006

Journal Articles

Tandem Cycle High-Dose Melphalan and Busulfan/Cyclophosphamide Followed by Maintenance Interferon Alpha-2 (IF) with or without Thalidomide (Thal) Is Associated with High Complete and Very Good Partial Response Rates, Improved Progression-Free, and Overall Survival.

George Somlo, MD, Dajun Qian, PhD, Firoozeh Sahebi, MD, Neil Martin Kogut, MD, Roberto Rodriguez, MD, Pablo Miguel Parker, MD, Leslie Popplewell, MD, Amrita Krishnan, MD, Joycelynne Palmer, PhD, Anthony Selwyn Stein, MD, Ricardo Spielberger, MD, Jeffrey Schriber, MD, Joseph Alvarnas, MD, Warren Chow, MD, Auayporn Nademanee, MD, Jasmine M. Zain, MD, Margaret R. O’Donnell, MD, Stephen J. Forman, MD

Blood (2006) 108 (11): 3089.

https://doi.org/10.1182/blood.V108.11.3089.3089

Published: 2006

Journal Articles

90 Y-Ibritumomab Tiuxetan (Zevalin®) in Combination with High-Dose Therapy (HDT) Followed by Autologous Stem Cell Transplant (ASCT) May Improve Survival in Patients with Poor-Risk Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL): Results of a Retrospective Comparative Analysis.

Auayporn P. Nademanee, MD, Amrita Krishnan, M.D, Nicole Tsai, MS, MPH, Joycelynne Palmer, Ph.D., Arturo Molina, M.D., Henry C. Fung, M.D., David Yamauchi, M.D, Neil Martin Kogut, M.D., Stephen J. Forman, M.D., Andrew Raubitschek, M.D.

Blood (2006) 108 (11): 327.

https://doi.org/10.1182/blood.V108.11.327.327

Published: 2006

Journal Articles

The Impact of Disease Status on the Outcome of High-Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT) for Peripheral T-Cell Lymphoma (PTCL).

Auayporn P. Nademanee, MD, Jasmine M. Zain, M.D., Joycelynne Palmer, Ph.D., Nicole Tsai, M.S., M.P.H., Neil Martin Kogut, M.D., Amrita Krishnan, M.D., Leslie Popplewell, M.D., Roberto Rodriguez, M.D., Eileen Patricia Smith, M.D., Stephen J. Forman, M.D.

Blood (2006) 108 (11): 3060.

https://doi.org/10.1182/blood.V108.11.3060.3060

Published: 2006

Journal Articles

Degradation of Bovine Factor VIII by Plasmin and Trypsin

Edward P. Kirby, Ph.D., Neil Martin, Victor J. Marder, M.D.

Blood (1974) 43 (5): 629–640.

https://doi.org/10.1182/blood.V43.5.629.629

Published: 1974

NARROW

Phase I-II Trial of Tandem Autologous Transplantation with Melphalan Followed by Total Marrow Irradiation Ablative Therapy in Patients with Responding or Stable Mutiple Myeloma.

Conditional Survival and Cause-Specific Mortality in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Hematologic Malignancy Over Three Decades

Comparative Analysis of Autologous Hematopoietic Cell Transplantation with Radioimmunotherapy (RIT) Based Conditioning Versus Total Body Irradiation (TBI) for High-Risk Diffuse Large Cell Lymphoma (DLCL): Toxicity and Efficacy

Extramedullary Relapse Following Reduced Intensity AlloHCT for Adult AML.

Early Mortality After Hematopoietic Cell Transplantation (HCT) for Hematologic Malignancies Performed In the Recent Era

High Rate of Complete Remission (CR) and Upgraded Response with Weekly Maintenance Bortezomib Post Single Autologous Peripheral Stem Cell Transplant (PSCT) In Patients with Multiple Myeloma. Results of a Phase II Prospective Study

A Phase II Study of Sequential Velcade/Thalidomide/ Dexamethasone (VTD) as Maintenance Therapy Post Single Autologous Peripheral Stem Cell (PSCT) in Patients with Multiple Myeloma.

Total Marrow Irradiation (TMI): A New Ablative Regimen as Part of Tandem (T) Autologous Peripheral Blood Progenitor Cell Transplant (AT) for Patients (pts) with Multiple Myeloma (MM).

Similar Outcome with Early Reduced Intensity Conditioning (RIC) Allogeneic Transplant to Autologous-Non-Myeloablative Allogeneic (Auto-Allo) Transplant in Patients with Multiple Myeloma.

Peripheral Hematopoietic Stem Cell Mobilization and Collection Efficacy Is Not an Independent Prognostic Factor for Autologous Stem Cell Transplantation.

Tandem Cycle High-Dose Melphalan and Busulfan/Cyclophosphamide Followed by Maintenance Interferon Alpha-2 (IF) with or without Thalidomide (Thal) Is Associated with High Complete and Very Good Partial Response Rates, Improved Progression-Free, and Overall Survival.

90 Y-Ibritumomab Tiuxetan (Zevalin®) in Combination with High-Dose Therapy (HDT) Followed by Autologous Stem Cell Transplant (ASCT) May Improve Survival in Patients with Poor-Risk Follicular Lymphoma (FL) and Diffuse Large B-Cell Lymphoma (DLBCL): Results of a Retrospective Comparative Analysis.

The Impact of Disease Status on the Outcome of High-Dose Therapy (HDT) and Autologous Stem Cell Transplantation (ASCT) for Peripheral T-Cell Lymphoma (PTCL).

Degradation of Bovine Factor VIII by Plasmin and Trypsin

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only